- Home
- MRNA vs VLTO Comparison
MRNA vs VLTO Comparison
Compare MRNA & VLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | VLTO |
|---|---|---|
| Founded | 2010 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 22.2B |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MRNA | VLTO |
|---|---|---|
| Price | $54.04 | $89.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $34.27 | ★ $108.90 |
| AVG Volume (30 Days) | ★ 5.3M | 1.7M |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ 21.77 | 12.57 |
| EPS | N/A | ★ 3.76 |
| Revenue | ★ $19,263,000,000.00 | $5,503,000,000.00 |
| Revenue This Year | $9.36 | $8.49 |
| Revenue Next Year | $15.43 | $5.29 |
| P/E Ratio | ★ N/A | $24.06 |
| Revenue Growth | 4.29 | ★ 5.97 |
| 52 Week Low | $22.28 | $84.99 |
| 52 Week High | $59.55 | $110.11 |
Technical Indicators
Market Signals| Indicator | MRNA | VLTO |
|---|---|---|
| Relative Strength Index (RSI) | 57.28 | 48.21 |
| Support Level | $47.61 | $88.40 |
| Resistance Level | $54.94 | $103.72 |
| Average True Range (ATR) | 2.58 | 1.61 |
| MACD | 0.30 | 0.36 |
| Stochastic Oscillator | 75.46 | 50.49 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments: water quality, product quality, and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.5 billion in revenue in 2025.